Arkolith/Insider Trading/ATYR/Form 4

Broadfoot Jill Marie

Chief Financial OfficeraTYR PHARMA INC (ATYR) · full profile →Form 4 · filed Feb 4, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$5K
Net Open-Market Flow
-$5K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 4, 2025Sell(S)1K$3.78$5K32K
Feb 3, 2025Option exercise(M)4K——33K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 3, 2025Option exercise(M)4K—$04K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-013884) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML